Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...
MJH Life Sciences acquired BPD Healthcare, a 2025 MM+M Agency 100 honoree. Kenvue said it told the FDA its labeling request is unsupported by scientific evidence and would mark a departure from the ...
Final results from the pivotal CheckMate 238 trial showed adjuvant nivolumab continues to significantly improve RFS compared with ipilimumab for patients with advanced melanoma, according to data ...
Iams, MD, MSCI, examined outcomes of the phase 3 IMforte trial in extensive-stage small cell lung cancer. Adding immunotherapy to platinum-based chemotherapy is an established standard of care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback